Gujarat Themis Biosyn shareholders approve borrowing limits

Gujarat Themis Biosyn Limited shareholders have approved special resolutions to increase the company's borrowing powers and authorize loans exceeding statutory limits. The resolutions were passed through a remote e-voting process conducted by Central Depository Services (India) Limited (CDSL), with the scrutinizer's report confirming the results on June 4, 2026.

The first special resolution sought approval to increase borrowing limits under Section 180(1)(c) and to create mortgages or charges on the company's assets under Section 180(1)(a) of the Companies Act, 2013. The second resolution aimed to approve limits for giving loans, guarantees, or investments, and to acquire securities of other body corporates in excess of the limits prescribed in Section 186 of the Companies Act, 2013.

Voting Results

The voting process saw participation from various shareholder categories, including promoters and public institutions. The resolutions were passed with a strong majority, though public institutions largely voted against the proposals.

Resolution 1: Borrowing Limits and Mortgage Creation

Category	Votes For	Votes Against	% For	% Against
Promoter and Promoter Group	76,557,741	0	100.00	0.00
Public-Institutions	679	1,277,290	0.05	99.95
Public-Non Institutions	1,517,379	739	99.95	0.05
Total	78,075,799	1,278,029	98.39	1.61

Resolution 2: Loans and Investments Limits

Category	Votes For	Votes Against	% For	% Against
Promoter and Promoter Group	76,557,741	0	100.00	0.00
Public-Institutions	679	1,277,290	0.05	99.95
Public-Non Institutions	1,516,094	6,524	99.57	0.43
Total	78,074,514	1,283,814	98.38	1.62

Procedural Details

The remote e-voting facility was available from May 6, 2026, at 9:00 a.m. IST until June 4, 2026, at 5:00 p.m. IST. CS Ketan Ravindra Shirwadkar of KRS AND CO. served as the scrutinizer for the postal ballot process. The notice for the postal ballot was sent electronically on May 5, 2026, to members whose email addresses were registered as of the cut-off date of May 1, 2026. Advertisements regarding the dispatch of notices were published in the "Western Times" (English and Gujarati editions) on May 6, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.92%	+3.59%	+6.73%	-10.12%	+17.83%	+61.63%

Gujarat Themis Biosyn Limited has expanded its international footprint by incorporating a wholly owned subsidiary, Themis Biosyn Ireland Private Limited, in Ireland on May 29, 2026. The strategic move marks the company's entry into the European market, with the new entity operating within the pharmaceutical industry. Gujarat Themis Biosyn holds 100% of the shareholding in the subsidiary, ensuring complete control over its operations.

The disclosure was made to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The subsidiary was registered with a share capital of 1,00,000 Euro. The Business registration extract for the new entity was received on the same date as its incorporation.

Details regarding the new subsidiary were provided in an annexure to the regulatory filing. The document clarified that the incorporation does not constitute a related party transaction, nor does it involve any interest from the promoter, promoter group, or other group companies. Consequently, specific details regarding acquisition costs, consideration, and regulatory approvals were noted as not applicable.

Subsidiary Details

The following table outlines the key particulars of the newly incorporated entity:

Particulars	Details
Name of the target entity	Themis Biosyn Ireland Private Limited
Country of Incorporation	Ireland
Share capital	1,00,000 Euro
Industry	Pharmaceutical Industry
Percentage of shareholding	100%
Date of Incorporation	May 29, 2026

The filing was signed by Dinesh S. Patel, Chairman & Director of Gujarat Themis Biosyn Limited. The information has been submitted to BSE Limited and the National Stock Exchange of India Limited for public dissemination.